Improving treatment of carcinomas via precision imaging of the tumour microenvironment with Copper-61 Kalios

Research unit

INNOSUISSE

Project number

100.918 IP-LS

Project title

Improving treatment of carcinomas via precision imaging of the tumour microenvironment with Copper-61 Kalios (Innolink: 100.918 IP-LS)

Texts for this project

	German	French	Italian	English
Key words	-	-	-
Abstract	-	-	-

Category	Text
Key words (English)	Life sciences, Human medicine
Abstract (English)	Accurate diagnosis is critical in determining the right therapy for carcinoma patients, leading to improved survival rates and quality of life. Nuclidium AG is developing Kalios, a diagnostic agent that enables precise imaging of carcinomas, overcoming all limitations of current imaging modalities.